use of phenylephrine paracetamol hydrochloride, a medicine, method of treating upper respiratory tract mucosal congestion in an adult human use of phenylephrine hydrochloride (or a pharmaceutically acceptable alternative form of phenylephrine) and paracetamol in the manufacture of a combined medicine for upper respiratory tract mucosal congestion treatment, comprising combining such substances with excipients, characterized in that the medicament has phenylephrine hydrochloride (or the pharmaceutically acceptable alternative form of phenylephrine) and paracetamol in appropriate proportions, and the medicament is intended for administration to an adult of: (a) 4 mg - 7.5 mg phenylephrine hydrochloride (or an equivalent amount of a pharmaceutically acceptable alternative) in combination with 950 mg - 1,000 mg paracetamol； or (b) 5 mg - 7.5 mg phenylephrine hydrochloride (or an equivalent alternative pharmaceutically acceptable amount of phenylephrine) in combination with 600 mg - 700 mg paracetamol； or c) 6 mg - 8 mg of phenylephrine hydrochloride (or an equivalent amount of an alternatively pharmaceutically acceptable form of phenylephrine) in combination with 500 mg - 550 mg of acetaminophen.resumo uso de cloridrato de fenilefrina e paracetamol, medicamento, método de tratamento de congestão das mucosas do trato respiratório superior em um humano adulto uso de cloridrato de fenilefrina (ou uma forma alternativa farmaceuticamente aceitável de fenilefrina) e paracetamol na produção de um medicamento combinado para tratamento de congestão das mucosas do trato respiratório superior, compreendendo a combinação de tais substâncias com excipientes, caracterizado pelo fato de o medicamento apresentar o cloridrato de fenilefrina (ou a forma alternativa farmaceuticamente aceitável de fenilefrina) e paracetamol em proporções adequadas, e o medicamento se destina, para a administração a um adulto de: a) 4 mg – 7,5 mg de cloridrato de fenilefrina (ou uma quantidade equivalente d
